Vat-Ho Vatnak
SEC insider (Form 3/4/5 filer). CIK 0002160022. Chief Business Officer at Akari Therapeutics Plc (AKTX). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 12, 2026. Located in TAMPA, FL.
Companies Vat-Ho Vatnak has filed insider reports for
- Akari Therapeutics Plc (AKTX): Officer, Chief Business Officer
Vat-Ho Vatnak
CIK: 0002160022
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKTX
Akari Therapeutics Plc
Officer